Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR
Status:
Completed
Trial end date:
2006-06-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy, safety and patient acceptability of
Somatuline Autogel in patients with acromegaly previously treated with octreotide LAR.